• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤免疫中的信号转导固有受体。

Signal-transducing innate receptors in tumor immunity.

机构信息

Department of Inflammology, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.

出版信息

Cancer Sci. 2021 Jul;112(7):2578-2591. doi: 10.1111/cas.14848. Epub 2021 May 1.

DOI:10.1111/cas.14848
PMID:33570784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8253268/
Abstract

The signal-transducing innate receptors represent classes of pattern recognition receptors (PRRs) that play crucial roles in the first line of the host defense against infections by the recognition of pathogen-derived molecules. Because of their poorly discriminative nature compared with antigen receptors of the adaptive immune system, they also recognize endogenous molecules and evoke immune responses without infection, resulting in the regulation of tumor immunity. Therefore, PRRs may be promising targets for effective cancer immunotherapy, either by activating or inhibiting them. Here, we summarize our current knowledge of signal-transducing PRRs in the regulation of tumor immunity.

摘要

信号转导固有受体代表了一类模式识别受体 (PRRs),它们在宿主防御感染的第一线中发挥着至关重要的作用,通过识别病原体衍生的分子来实现。与适应性免疫系统的抗原受体相比,由于它们的区分能力较差,因此它们也可以识别内源性分子,并在没有感染的情况下引发免疫反应,从而调节肿瘤免疫。因此,PRRs 可能是有效癌症免疫治疗的有前途的靶点,无论是通过激活还是抑制它们。在这里,我们总结了我们目前对信号转导 PRRs 在肿瘤免疫调节中的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623b/8253268/3689929945a1/CAS-112-2578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623b/8253268/3689929945a1/CAS-112-2578-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/623b/8253268/3689929945a1/CAS-112-2578-g002.jpg

相似文献

1
Signal-transducing innate receptors in tumor immunity.肿瘤免疫中的信号转导固有受体。
Cancer Sci. 2021 Jul;112(7):2578-2591. doi: 10.1111/cas.14848. Epub 2021 May 1.
2
Promising targets based on pattern recognition receptors for cancer immunotherapy.基于模式识别受体的癌症免疫治疗有前景的靶点。
Pharmacol Res. 2020 Sep;159:105017. doi: 10.1016/j.phrs.2020.105017. Epub 2020 Jun 16.
3
Toll-Like Receptors Signaling in the Tumor Microenvironment.肿瘤微环境中的 Toll 样受体信号转导。
Adv Exp Med Biol. 2020;1223:81-97. doi: 10.1007/978-3-030-35582-1_5.
4
Application of dsRNA in cancer immunotherapy: current status and future trends.dsRNA 在癌症免疫治疗中的应用:现状与未来趋势。
Anticancer Agents Med Chem. 2014 Feb;14(2):241-55. doi: 10.2174/18715206113136660373.
5
Recognition of bacterial infection by innate immune sensors.先天免疫传感器对细菌感染的识别。
Crit Rev Microbiol. 2013 Aug;39(3):229-46. doi: 10.3109/1040841X.2012.706249. Epub 2012 Aug 6.
6
Pattern recognition receptors acting in innate immune system of shrimp against pathogen infections.模式识别受体在虾先天免疫系统中对病原体感染的作用。
Fish Shellfish Immunol. 2013 Apr;34(4):981-9. doi: 10.1016/j.fsi.2012.08.008. Epub 2012 Aug 31.
7
[Signal transduction of innate immunity to virus infection].[病毒感染的固有免疫信号转导]
Bing Du Xue Bao. 2012 May;28(3):303-10.
8
Innate recognition of microbial-derived signals in immunity and inflammation.固有免疫识别微生物来源的信号在免疫和炎症中的作用。
Sci China Life Sci. 2016 Dec;59(12):1210-1217. doi: 10.1007/s11427-016-0325-6. Epub 2016 Nov 23.
9
[Pattern recognition receptors].[模式识别受体]
Nihon Rinsho Meneki Gakkai Kaishi. 2011;34(5):329-45. doi: 10.2177/jsci.34.329.
10
Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.模式识别受体:先天免疫中的哨兵和新型疫苗佐剂的靶标。
Expert Rev Vaccines. 2012 Feb;11(2):237-56. doi: 10.1586/erv.11.189.

引用本文的文献

1
Supersulfide donors and their therapeutic targets in inflammatory diseases.超硫化物供体及其在炎症性疾病中的治疗靶点。
Front Immunol. 2025 Apr 16;16:1581385. doi: 10.3389/fimmu.2025.1581385. eCollection 2025.
2
N4BP3 facilitates NOD2-MAPK/NF-κB pathway in inflammatory bowel disease through mediating K63-linked RIPK2 ubiquitination.N4BP3通过介导K63连接的RIPK2泛素化促进炎症性肠病中的NOD2-MAPK/NF-κB信号通路。
Cell Death Discov. 2024 Oct 17;10(1):440. doi: 10.1038/s41420-024-02213-x.
3
Autophagy-related long non-coding RNAs act as prognostic biomarkers and associate with tumor microenvironment in prostate cancer.

本文引用的文献

1
Harnessing innate immunity in cancer therapy.利用先天免疫进行癌症治疗。
Nature. 2019 Oct;574(7776):45-56. doi: 10.1038/s41586-019-1593-5. Epub 2019 Oct 2.
2
Chromatin-bound cGAS is an inhibitor of DNA repair and hence accelerates genome destabilization and cell death.染色质结合的 cGAS 是 DNA 修复的抑制剂,因此加速了基因组的不稳定性和细胞死亡。
EMBO J. 2019 Oct 4;38(21):e102718. doi: 10.15252/embj.2019102718. Epub 2019 Sep 23.
3
The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis.
自噬相关长链非编码RNA作为前列腺癌的预后生物标志物并与肿瘤微环境相关。
Am J Cancer Res. 2024 Feb 15;14(2):545-561. doi: 10.62347/XTDZ5687. eCollection 2024.
4
Differential gene expression of immunity and inflammation genes in colorectal cancer using targeted RNA sequencing.使用靶向RNA测序技术分析结直肠癌中免疫和炎症基因的差异基因表达
Front Oncol. 2023 Oct 5;13:1206482. doi: 10.3389/fonc.2023.1206482. eCollection 2023.
5
RIG-I-mediated innate immune signaling in tumors reduces the therapeutic effect of oncolytic vesicular stomatitis virus.RIG-I 介导的肿瘤固有免疫信号转导降低了溶瘤单纯疱疹病毒的治疗效果。
Thorac Cancer. 2023 Jan;14(3):246-253. doi: 10.1111/1759-7714.14740. Epub 2022 Nov 29.
6
Au naturale: use of biologically derived cyclic di-nucleotides for cancer immunotherapy.自然状态:生物衍生的环状二核苷酸在癌症免疫治疗中的应用。
Open Biol. 2021 Dec;11(12):210277. doi: 10.1098/rsob.210277. Epub 2021 Dec 15.
7
Pathophysiological Implication of Pattern Recognition Receptors in Fetal Membranes Rupture: RAGE and NLRP Inflammasome.模式识别受体在胎膜破裂中的病理生理意义:晚期糖基化终末产物受体与NLRP炎性小体
Biomedicines. 2021 Aug 31;9(9):1123. doi: 10.3390/biomedicines9091123.
8
Pattern recognition receptors in health and diseases.模式识别受体在健康与疾病中的作用
Signal Transduct Target Ther. 2021 Aug 4;6(1):291. doi: 10.1038/s41392-021-00687-0.
巨噬细胞四跨膜蛋白 4A4A 增强了依赖 Dectin-1 的 NK 细胞介导的转移抵抗能力。
Nat Immunol. 2019 Aug;20(8):1012-1022. doi: 10.1038/s41590-019-0417-y. Epub 2019 Jul 1.
4
Glial TLR2-driven innate immune responses and CD8 T cell activation against brain tumor.胶质细胞 TLR2 驱动的固有免疫反应和 CD8 T 细胞对脑肿瘤的激活作用。
Glia. 2019 Jun;67(6):1179-1195. doi: 10.1002/glia.23597. Epub 2019 Feb 5.
5
Nuclear cGAS suppresses DNA repair and promotes tumorigenesis.核 cGAS 抑制 DNA 修复并促进肿瘤发生。
Nature. 2018 Nov;563(7729):131-136. doi: 10.1038/s41586-018-0629-6. Epub 2018 Oct 24.
6
Targeting Toll-Like Receptors for Cancer Therapy.靶向 Toll 样受体进行癌症治疗。
Target Oncol. 2018 Oct;13(5):583-598. doi: 10.1007/s11523-018-0589-7.
7
Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.靶向细胞溶质核酸感应途径的癌症免疫治疗。
Front Immunol. 2018 Apr 9;9:711. doi: 10.3389/fimmu.2018.00711. eCollection 2018.
8
Understanding the tumor immune microenvironment (TIME) for effective therapy.理解肿瘤免疫微环境(TIME)以实现有效的治疗。
Nat Med. 2018 May;24(5):541-550. doi: 10.1038/s41591-018-0014-x. Epub 2018 Apr 23.
9
Chromosomal instability drives metastasis through a cytosolic DNA response.染色体不稳定性通过细胞质 DNA 反应驱动转移。
Nature. 2018 Jan 25;553(7689):467-472. doi: 10.1038/nature25432. Epub 2018 Jan 17.
10
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.TLR 激动剂与检查点抑制剂联合免疫疗法抑制头颈部癌症。
JCI Insight. 2017 Sep 21;2(18). doi: 10.1172/jci.insight.93397.